Literature DB >> 8336165

Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?

T E Feasby1, A F Hahn, W F Brown, C F Bolton, J J Gilbert, W J Koopman.   

Abstract

Four cases of severe acute Guillain-Barré syndrome (GBS) characterized by severe axonal degeneration are presented. All had electrically inexcitable motor nerves as early as 4 days after onset. The disease was rapid in onset and the residual disability was severe. Two different types of pathology were seen. Nerve biopsies in 3 cases showed severe axonal degeneration without inflammation or demyelination. Autopsy in one of these cases showed that the dorsal and ventral roots were also significantly affected. These cases illustrate the primary axonal form of GBS. Nerve biopsy in the fourth case at day 15 showed marked inflammation and demyelination with axonal degeneration. Contralateral nerve biopsy at day 75 showed almost complete loss of axons. This case illustrates another type of axonal degeneration, that which occurs secondary to inflammation and demyelination.

Entities:  

Mesh:

Year:  1993        PMID: 8336165     DOI: 10.1016/0022-510x(93)90324-r

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

2.  Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Kiichi Unoda; Kazushi Yamane; Yoshimitsu Doi; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2016-06-08       Impact factor: 4.849

3.  Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken.

Authors:  Kishan K Nyati; Kashi N Prasad; Nagendra K Kharwar; Priyanka Soni; Nuzhat Husain; Vinita Agrawal; Arun K Jain
Journal:  Med Microbiol Immunol       Date:  2011-11-19       Impact factor: 3.402

4.  Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni.

Authors:  F J Vriesendorp; W J Triggs; R F Mayer; C L Koski
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

5.  An electrophysiological classification associated with Guillain-Barré syndrome outcomes.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Kiichi Unoda; Kazushi Yamane; Yoshimitsu Doi; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2014-08-01       Impact factor: 4.849

6.  Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome.

Authors:  C Y Li; P Xue; W Q Tian; R C Liu; C Yang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

Review 7.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

8.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

9.  Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin.

Authors:  Hui Qing Hou; Jun Miao; Xue Dan Feng; Mei Han; Xiu Juan Song; Li Guo
Journal:  BMC Neurol       Date:  2014-10-15       Impact factor: 2.474

10.  Atypical Electrophysiological Findings in a Patient with Acute Motor and Sensory Axonal Neuropathy.

Authors:  Viviana Versace; Stefania Campostrini; Frediano Tezzon; Sara Martignago; Markus Kofler; Leopold Saltuari; Luca Sebastianelli; Raffaele Nardone
Journal:  Front Neurol       Date:  2017-11-08       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.